In a recent study by Han et al., 2018, Luteolin was identified to suppress the Wnt signaling by upregulating frizzled class receptor 6 (FZD6), the negative regulator of β-catenin transcriptional activity, and causing the inhibition of the stemness of prostate cancer cells [79]. The gene discussed is FZD6; the disease is Familial prostate cancer.